Product Pathways - Chromatin Regulation / Epigenetics
CTCF (D31H2) XP® Rabbit mAb #3418
|3418S||100 µl (10 western blots)||---||In Stock||---|
|3418P||40 µl (4 western blots)||---||In Stock||---|
|3418||carrier free and custom formulation / quantity||email request|
Already purchased this product? Write a Review.
|W||1:1000||Human, Mouse, Rat, Monkey||Endogenous||140||Rabbit IgG|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting, IP=Immunoprecipitation, IHC-P=Immunohistochemistry (Paraffin), IF-IC=Immunofluorescence (Immunocytochemistry), ChIP=Chromatin IP
Species predicted to react based on 100% sequence homology: Bovine, Horse.
Specificity / Sensitivity
CTCF (D31H2) XP® Rabbit mAb detects endogenous levels of total CTCF protein. This antibody does not cross-react with BORIS.
Source / Purification
Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to the carboxy terminus of the human CTCF protein.
Western blot analysis of extracts from various cell lines using CTCF (D31H2) XP® Rabbit mAb.
Immunohistochemical analysis of paraffin-embedded human breast carcinoma using CTCF (D31H2) XP® Rabbit mAb in the presence of control peptide (left) or antigen-specific peptide (right).
Immunohistochemical analysis of paraffin-embedded human colon carcinoma using CTCF (D31H2) XP® Rabbit mAb.
Immunohistochemical analysis of paraffin-embedded human lymphoma using CTCF (D31H2) XP® Rabbit mAb.
Confocal immunofluorescent analysis of HCT-116 cells using CTCF (D31H2) XP® Rabbit mAb (green). Actin filaments were labeled with DY-554 phalloidin (red).
Chromatin immunoprecipitations were performed with cross-linked chromatin from 4 x 106 HeLa cells, with either 10 μl of CTCF (D31H2) XP® Rabbit mAb or 2 μl of Normal Rabbit IgG #2729, using SimpleChIP® Enzymatic Chromatin IP Kit (Magnetic Beads) #9003. The enriched DNA was quantified by real-time PCR using human c-Myc promoter primers, SimpleChIP® Human H19/Igf2 ICR Primers #5172, and SimpleChIP® Human α Satellite Repeat Primers #4486. The amount of immunoprecipitated DNA in each sample is represented as signal relative to the total amount of input chromatin, which is equivalent to one.
CCCTC-binding factor (CTCF) and its paralog, the Brother of the Regulator of Imprinted Sites (BORIS), are highly conserved transcription factors that regulate transcriptional activation and repression, insulator function, and imprinting control regions (ICRs) (1-4). Although they have divergent amino and carboxy termini, both proteins contain 11 conserved zinc finger domains that work in combination to bind the same DNA elements (1). CTCF is ubiquitously expressed and contributes to transcriptional regulation of cell-growth regulated genes, including c-myc, p19/ARF, p16/INK4A, BRCA1, p53, p27, E2F1, and TERT (1). CTCF also binds to and is required for the enhancer-blocking activity of all known insulator elements and ICRs, including the H19/IgF2, Prader-Willi/Angelman syndrome, and Inactive X-Specific Transcript (XIST) anti-sense loci (5-7). CTCF DNA-binding is sensitive to DNA methylation, a mark that determines selection of the imprinted allele (maternal vs. paternal) (1). The various functions of CTCF are regulated by at least two different post-translational modifications. Poly(ADP-ribosyl)ation of CTCF is required for insulator function (8). Phosphorylation of Ser612 by protein kinase CK2 facilitates a switch of CTCF from a transcriptional repressor to an activator at the c-myc promoter (9). CTCF mutations or deletions have been found in many breast, prostate, and Wilms tumors (10,11). Expression of BORIS is restricted to spermatocytes and is mutually exclusive of CTCF (3). In cells expressing BORIS, promoters of X-linked cancer-testis antigens like MAGE-1A are demethylated and activated, but methylated and inactive in CTCF-expressing somatic cells (12). Like other testis specific proteins, BORIS is abnormally expressed in different cancers, such as breast cancer, and has a greater affinity than CTCF for DNA binding sites, detracting from CTCF’s potential tumor suppressing activity (1,3,13,14).
- Klenova, E.M. et al. (2002) Semin Cancer Biol 12, 399-414.
- Klenova, E.M. et al. (1993) Mol Cell Biol 13, 7612-24.
- Loukinov, D.I. et al. (2002) Proc Natl Acad Sci USA 99, 6806-11.
- Mukhopadhyay, R. et al. (2004) Genome Res 14, 1594-602.
- Hark, A.T. et al. (2000) Nature 405, 486-9.
- Ohta, T. et al. (1999) Am J Hum Genet 64, 397-413.
- Chao, W. et al. (2002) Science 295, 345-7.
- Yu, W. et al. (2004) Nat Genet 36, 1105-10.
- El-Kady, A. and Klenova, E. (2005) FEBS Lett 579, 1424-34.
- Filippova, G.N. et al. (1998) Genes Chromosomes Cancer 22, 26-36.
- Filippova, G.N. et al. (2002) Cancer Res 62, 48-52.
- Vatolin, S. et al. (2005) Cancer Res 65, 7751-62.
- Hong, J.A. et al. (2005) Cancer Res 65, 7763-74.
- D'Arcy, V. et al. (2008) Br J Cancer 98, 571-9.
- Shukla, S. et al. (2011) Nature 479, 74-9. Applications: Western Blotting.
- Tang, M. et al. (2011) Proc Natl Acad Sci U S A 108, 15231-6. Applications: Western Blotting.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 2160 DNMT3A Antibody
- 7071 Phototope®-HRP Western Blot Detection System, Anti-rabbit IgG, HRP-linked Antibody
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7720 Prestained Protein Marker, Broad Range (Premixed Format)
- 7727 Biotinylated Protein Ladder Detection Pack
- 7003 20X LumiGLO® Reagent and 20X Peroxide
- 8112 SignalStain® Antibody Diluent
For Research Use Only. Not For Use In Diagnostic Procedures.
XP® is a trademark of Cell Signaling Technology, Inc.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.